Cargando…

P53 prevent tumor invasion and metastasis by down-regulating IDO in lung cancer

In present study, we are to clear demonstrate the genetic evidence of IDO signaling's impact on invasion and metastasis in lung cancer. Here we examined IDO1 expression levels in non-small cell lung cancer (NSCLC) patients (64) tumor/normal pairs underwent RT-PCR and comprehensive histological,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Dongfang, Yue, Lu, Yao, Ruyong, Zhou, Lin, Yang, Yuqin, Lu, Liming, Gao, Wen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5589602/ https://www.ncbi.nlm.nih.gov/pubmed/28903363 http://dx.doi.org/10.18632/oncotarget.17408

Ejemplares similares

The miR‐3127‐5p/p‐STAT3 axis up‐regulates PD‐L1 inducing chemoresistance in non‐small‐cell lung cancer
por: Tang, Dongfang, et al.
Publicado: (2018)

Trichostatin A reverses the chemoresistance of lung cancer with high IGFBP2 expression through enhancing autophagy
por: Tang, Dongfang, et al.
Publicado: (2018)

Gain-of-Function Mutations in p53 in Cancer Invasiveness and Metastasis
por: Roszkowska, Katarzyna A., et al.
Publicado: (2020)

Mutant p53 regulates Survivin to foster lung metastasis
por: Tang, Qiaosi, et al.
Publicado: (2021)

LEM domain containing 1 promotes pancreatic cancer growth and metastasis by p53 and mTORC1 signaling pathway
por: Cao, Xiang, et al.
Publicado: (2022)

IDO in Colorectal Tumorigenesis: Involvement of Immune Tolerance and Significance in Prevention and Therapy
por: Tang, Shunan, et al.
Publicado: (2021)

lncRNA PTAR promotes NSCLC cell proliferation, migration and invasion by sponging microRNA-101
por: Yu, Wenjun, et al.
Publicado: (2019)

IDO1 Modulates the Sensitivity of Epithelial Ovarian Cancer Cells to Cisplatin through ROS/p53-Dependent Apoptosis
por: Wang, Houmei, et al.
Publicado: (2022)

Down-regulation of Skp2 expression inhibits invasion and lung metastasis in osteosarcoma
por: Zhang, Yidan, et al.
Publicado: (2018)

Impact of IDO1 and IDO2 on the B Cell Immune Response
por: Merlo, Lauren M. F., et al.
Publicado: (2022)

Knocking down USP39 Inhibits the Growth and Metastasis of Non-Small-Cell Lung Cancer Cells through Activating the p53 Pathway
por: Yuan, Jiahui, et al.
Publicado: (2020)

IDO1 plays a tumor-promoting role via MDM2-mediated suppression of the p53 pathway in diffuse large B-cell lymphoma
por: Sun, Chengtao, et al.
Publicado: (2022)

Depletion of R270C Mutant p53 in Osteosarcoma Attenuates Cell Growth but Does Not Prevent Invasion and Metastasis In Vivo
por: Shimizu, Takatsune, et al.
Publicado: (2022)

1-MT inhibits the invasion of CBP-resistant ovarian cancer cells via down-regulating IDO expression and re-activating immune cells function
por: Ma, Huihan, et al.
Publicado: (2020)

p53 targets TSPAN8 to prevent invasion in melanoma cells
por: Agaësse, G, et al.
Publicado: (2017)

p53-Autophagy-Metastasis Link
por: Denisenko, Tatiana V., et al.
Publicado: (2018)

Down-regulation of tissue factor inhibits invasion and metastasis of non-small cell lung cancer
por: Xia, Qing, et al.
Publicado: (2020)

Differential Roles of IDO1 and IDO2 in T and B Cell Inflammatory Immune Responses
por: Merlo, Lauren M. F., et al.
Publicado: (2020)

Cardamonin suppressed the migration, invasion, epithelial mesenchymal transition (EMT) and lung metastasis of colorectal cancer cells by down-regulating ADRB2 expression
por: Lu, Ting, et al.
Publicado: (2022)

Activities of plasma indoleamine-2, 3-dioxygenase (IDO) enzyme in Nigerian patients with lung diseases: basis for tryptophan supplementation or IDO inhibitor use
por: Arinola, Ganiyu Olatunbosun, et al.
Publicado: (2023)

Toca-1 is suppressed by p53 to limit breast cancer cell invasion and tumor metastasis
por: Chander, Harish, et al.
Publicado: (2014)

Genetic Polymorphisms Affecting IDO1 or IDO2 Activity Differently Associate With Aspergillosis in Humans
por: Napolioni, Valerio, et al.
Publicado: (2019)

IDO-orchestrated crosstalk between pDCs and Tregs inhibits autoimmunity
por: Lippens, Carla, et al.
Publicado: (2016)

A triad of NRP2, DLX and p53 proteins in lung cancer metastasis
por: Drabkin, Harry A., et al.
Publicado: (2017)

Aging-associated increase in indoleamine 2,3-dioxygenase (IDO) activity appears to be unrelated to the transcription of the IDO1 or IDO2 genes in peripheral blood mononuclear cells
por: Marttila, Saara, et al.
Publicado: (2011)

Amyloid β neurotoxicity is IDO1–Kyn–AhR dependent and blocked by IDO1 inhibitor
por: Duan, Zhenzhen, et al.
Publicado: (2020)

Indoleamine 2,3‐dioxygenase (IDO)‐1 and IDO‐2 activity and severe course of COVID‐19
por: Guo, Lihui, et al.
Publicado: (2022)

Modulation of p53 expression in cancer-associated fibroblasts prevents peritoneal metastasis of gastric cancer
por: Ogawa, Toshihiro, et al.
Publicado: (2022)

IDO1 Activity Predicts Lung Toxicity in Patients with Unresectable Stage III NSCLC and Chemoradiotherapy
por: Wu, Linfang, et al.
Publicado: (2023)

HUWE1 controls the development of non-small cell lung cancer through down-regulation of p53
por: Yang, Dong, et al.
Publicado: (2018)

Evaluation of K-ras and p53 expression in pancreatic adenocarcinoma using the cancer genome atlas
por: Lu, Liming, et al.
Publicado: (2017)

p53‐inducible gene 3 promotes cell migration and invasion by activating the FAK/Src pathway in lung adenocarcinoma
por: Gu, Meng‐Meng, et al.
Publicado: (2018)

Selective targeting p53(WT) lung cancer cells harboring homozygous p53 Arg72 by an inhibitor of CypA
por: Lu, W, et al.
Publicado: (2017)

Pu-erh Tea Inhibits Tumor Cell Growth by Down-Regulating Mutant p53
por: Zhao, Lanjun, et al.
Publicado: (2011)

CD4 responses against IDO
por: Andersen, Mads Hald
Publicado: (2012)

IDO-GCN2 and autophagy in inflammation
por: McGaha, Tracy L.
Publicado: (2015)

IDO2 in Immunomodulation and Autoimmune Disease
por: Prendergast, George C., et al.
Publicado: (2014)

Discovery of Icotinib-1,2,3-Triazole Derivatives as IDO1 Inhibitors
por: Mao, Long-fei, et al.
Publicado: (2020)

Role of IDO and TDO in Cancers and Related Diseases and the Therapeutic Implications
por: Ye, Zixiang, et al.
Publicado: (2019)

IDO1 and IDO2 Non-Synonymous Gene Variants: Correlation with Crohn's Disease Risk and Clinical Phenotype
por: Lee, Alexander, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_cu6m7667k9vud4s6snqlts1o1d